GB201409478D0 - Pro-angiogenic signature - Google Patents

Pro-angiogenic signature

Info

Publication number
GB201409478D0
GB201409478D0 GBGB1409478.3A GB201409478A GB201409478D0 GB 201409478 D0 GB201409478 D0 GB 201409478D0 GB 201409478 A GB201409478 A GB 201409478A GB 201409478 D0 GB201409478 D0 GB 201409478D0
Authority
GB
United Kingdom
Prior art keywords
pro
angiogenic signature
angiogenic
signature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1409478.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almac Diagnostics Ltd
Original Assignee
Almac Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almac Diagnostics Ltd filed Critical Almac Diagnostics Ltd
Priority to GBGB1409478.3A priority Critical patent/GB201409478D0/en
Publication of GB201409478D0 publication Critical patent/GB201409478D0/en
Priority to PCT/GB2015/051558 priority patent/WO2015181556A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1409478.3A 2014-05-28 2014-05-28 Pro-angiogenic signature Ceased GB201409478D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1409478.3A GB201409478D0 (en) 2014-05-28 2014-05-28 Pro-angiogenic signature
PCT/GB2015/051558 WO2015181556A1 (en) 2014-05-28 2015-05-28 Pro-angiogenic expression signature

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1409478.3A GB201409478D0 (en) 2014-05-28 2014-05-28 Pro-angiogenic signature

Publications (1)

Publication Number Publication Date
GB201409478D0 true GB201409478D0 (en) 2014-07-09

Family

ID=51177581

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1409478.3A Ceased GB201409478D0 (en) 2014-05-28 2014-05-28 Pro-angiogenic signature

Country Status (2)

Country Link
GB (1) GB201409478D0 (en)
WO (1) WO2015181556A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3578981B1 (en) * 2018-06-06 2021-10-27 TUDAG TU Dresden Aktiengesellschaft Anti-cancer treatment of preselected subjects and screening methods to identify susceptible subjects

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013031019A2 (en) * 2011-06-02 2017-03-21 Almac Diagnostics Ltd molecular diagnostic test for cancer
RU2659173C2 (en) * 2012-01-13 2018-06-28 Дженентек, Инк. Biological markers for identifying patients for treatment with vegf antagonists
CA2893033A1 (en) * 2012-12-03 2014-06-12 Almac Diagnostics Limited Molecular diagnostic test for cancer

Also Published As

Publication number Publication date
WO2015181556A1 (en) 2015-12-03

Similar Documents

Publication Publication Date Title
DK3237446T3 (en) Anti-PD-1-antistoffer
DK3236972T3 (en) Antivirale N4-hydroxycytidin-derivativer
DK3373003T3 (en) Urinteststrimmel
AU361515S (en) Dishrack
AU362944S (en) Lapboard
DK3191586T3 (en) Cellobiosephosphorylase
DK3178931T3 (en) Anti-orai1-antistof
GB201408823D0 (en) Demulsifiers
DK3002465T3 (en) Hydrauliksystem
GB201401268D0 (en) TrackPack
DK3234061T3 (en) Nano-inhibitorer
GB201402083D0 (en) Retaining means
DK3194944T3 (en) Tomografiapparat
GB201409478D0 (en) Pro-angiogenic signature
DK3145380T3 (en) Toiletventilationssystem
AU5593P (en) Lanmissouri Mandevilla sanderi
AU5594P (en) Lanoregon Mandevilla sanderi
AU5585P (en) Lanutah Mandevilla sanderi
AU5598P (en) Lanidaho Mandevilla sanderi
AU5584P (en) Laniowa Mandevilla sanderi
AU5597P (en) Lancalifornia Mandevilla sanderi
AU5583P (en) Lanminnesota Mandevilla sanderi
AU5591P (en) Lanmontana Mandevilla sanderi
AU5596P (en) Lannevada Mandevilla sanderi
AU5285P (en) FLOMANRER Mandevilla sanderi

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)